US Broker Ratings

Charles River Laboratories (CRL) Stock Analysis: Navigating Growth and Challenges in the Healthcare Sector

Charles River Laboratories International, Inc. (NYSE: CRL) stands at a pivotal juncture in the healthcare sector, offering a fascinating blend of opportunity and challenge for investors. With a market capitalization..

Bausch + Lomb Corporation (BLCO): Investor Outlook on Eye Health Giant with a 5% Upside

Bausch + Lomb Corporation (BLCO), a renowned name in the healthcare sector, specifically within the medical instruments and supplies industry, presents a compelling investment opportunity with a potential upside of..

BrightSpring Health Services, I (BTSG) Stock Analysis: A Promising 12.38% Upside in the Healthcare Sector

BrightSpring Health Services, Inc. (BTSG) stands as a formidable player within the U.S. healthcare sector, specifically in the realm of Health Information Services. Operating primarily through its Pharmacy Solutions and..

TG Therapeutics, Inc. (TGTX) Investor Outlook: Exploring the 52.42% Potential Upside and Strategic Positioning in Biotechnology

TG Therapeutics, Inc. (NASDAQ: TGTX) has become a notable player in the biotechnology sector, capturing investor attention with its promising portfolio of treatments for B-cell mediated diseases. As a commercial-stage..

Cardinal Health, Inc. (CAH) Stock Analysis: Strong Revenue Growth and Analyst Optimism Signal Investment Potential

Cardinal Health, Inc. (NYSE: CAH) has positioned itself as a formidable player in the healthcare sector, specifically within the medical distribution industry. With a substantial market capitalization of $51.05 billion,..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Evaluating the 19.27% Potential Upside in Precision Oncology

Revolution Medicines, Inc. (NASDAQ: RVMD) is a clinical-stage biotechnology company making significant strides in the healthcare sector by focusing on precision oncology. Headquartered in Redwood City, California, Revolution Medicines is..

HealthEquity, Inc. (HQY) Investor Outlook: Unpacking a 39% Potential Upside

As the leading provider of health savings accounts (HSAs) and other consumer-directed benefits, HealthEquity, Inc. (NASDAQ: HQY) is capturing significant attention in the healthcare sector. With its innovative technology platforms..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 24.72% Upside Potential in the Healthcare Sector

Lantheus Holdings, Inc. (NASDAQ: LNTH) is making waves in the healthcare sector, and for good reason. With a strong focus on diagnostic and therapeutic products, the company has carved a..

Bio-Techne Corp (TECH) Stock Analysis: Unpacking the 9.22% Potential Upside Amidst Mixed Performance Metrics

Bio-Techne Corporation (NASDAQ: TECH) stands as a notable player in the biotechnology sector, with a robust presence in the healthcare industry. Valued at a market capitalization of $9.99 billion, this..

GSK plc (GSK) Stock Analysis: Navigating Market Leadership with Robust Dividend Yield and Strategic Collaborations

GSK plc (NYSE: GSK), a stalwart in the global healthcare landscape, is showing promising indicators for investors seeking a blend of stable income and potential growth. With a market capitalization..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating the Medical Device Market with Strategic Growth

Integer Holdings Corporation (NYSE: ITGR), a key player in the healthcare sector specializing in medical devices, presents an intriguing investment opportunity with its expansive product portfolio and strategic market positioning...

Biogen Inc. (BIIB) Stock Analysis: Navigating Healthcare with Strategic Collaborations and a 7.29% Upside

Biogen Inc. (BIIB), a prominent player in the healthcare sector, continues to be a compelling focus for investors who are keen on the pharmaceutical industry’s potential for innovation and growth...

Prestige Consumer Healthcare (PBH) Stock Analysis: Strong Buy Ratings Signal Nearly 20% Upside Potential

Prestige Consumer Healthcare Inc. (NYSE: PBH) is a prominent player in the healthcare sector, specifically within the drug manufacturers’ niche focusing on specialty and generic products. With a market capitalization..

Krystal Biotech, Inc. (KRYS) Investor Outlook: Navigating a Promising Biotech Landscape with a Strong Buy Consensus

Krystal Biotech, Inc. (NASDAQ: KRYS) is making waves in the biotechnology sector, with a market capitalization of $8.1 billion. This Pittsburgh-based company has positioned itself as a frontrunner in genetic..

RadNet, Inc. (RDNT) Stock Analysis: A Healthcare Powerhouse with 30.88% Upside Potential

RadNet, Inc. (NASDAQ: RDNT), a leading player in the healthcare diagnostics and research industry, stands as a compelling investment opportunity for those looking to capitalize on the burgeoning demand for..

Zimmer Biomet Holdings (ZBH) Stock Analysis: Potential 18% Upside in a Competitive Medical Devices Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands as a significant player within the healthcare sector, specifically in the medical devices industry. With a market capitalization of $17.26 billion, this Indiana-based..

West Pharmaceutical Services, Inc. (WST): Investor Outlook Reveals 49.58% Potential Upside

West Pharmaceutical Services, Inc. (NYSE: WST) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a current market capitalization of $16.63..

Sanofi (SNY) Investor Outlook: A Strong Buy with 23.72% Potential Upside

Sanofi (SNY), a titan in the healthcare sector, particularly within the general drug manufacturing industry, is garnering attention from investors due to its promising growth potential and robust dividend yield...

Cytokinetics, Incorporated (CYTK) Stock Analysis: A Biotech Play with a 41.55% Upside Potential

Cytokinetics, Incorporated (NASDAQ: CYTK), with a market capitalization of $7.73 billion, operates in the dynamic biotechnology industry within the healthcare sector. This late-stage biopharmaceutical company is at the frontier of..

Glaukos Corporation (GKOS) Stock Analysis: Exploring a 11.17% Upside in the Medical Devices Sector

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector specializing in medical devices, has been making waves with its innovative solutions for ophthalmic diseases. Headquartered in Aliso Viejo,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds